Adjuvant chemotherapy for non-small-cell lung cancer: The end of the beginning

Journal of the National Cancer Institute

Volumn 95, Issue 19, 2003, Pages 1422-1424

  Johnson, Bruse E ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; ETOPOSIDE; IFOSFAMIDE; MITOMYCIN; TEGAFUR; URACIL; VINDESINE;

CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL STUDY; CLINICAL TRIAL; DISEASE SEVERITY; DRUG WITHDRAWAL; EDITORIAL; HUMAN; INTERNATIONAL COOPERATION; LUNG NON SMALL CELL CANCER; LUNG RESECTION; PRIORITY JOURNAL; SIDE EFFECT; STATISTICAL SIGNIFICANCE; SURVIVAL TIME; TREATMENT OUTCOME; ADJUVANT CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; ITALY; LUNG TUMOR; MULTICENTER STUDY; NOTE; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; HUMANS; ITALY; LUNG NEOPLASMS; MULTICENTER STUDIES; NEOPLASM STAGING; RANDOMIZED CONTROLLED TRIALS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0141429028     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/djg077     Document Type: Editorial

References (12)

1. Scagliotti GV, Fossati R, Torri V, Crinò L, Giaccone G, Silvano G, et al. Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell lung cancer. J Natl Cancer Inst 2003;95: 1453-61.
2. Kato H, Tsuboi M, Ohta M, Hata E, Tsubota N, Hamajima N, et al. In: Grunberg SM, editor. A randomized phase III trial of adjuvant chemotherapy with UFT for completely resected pathological stage I (T1N0M0, T2N0M0) adenocarcinoma of the lung. Annual Meeting of the American Society of Clinical Oncology (ASCO); 2003 May 31-Jun 3; Chicago. Alexandria (VA): ASCO; 2003;22:621.
3. Le Chevalier T. In: Grunberg SM, editor. Results of the randomized international adjuvant lung cancer trial (IALT) cisplatin-based chemotherapy (CT) versus no CT in 1867 patients with resected non-small cell lung cancer. Annual Meeting of the American Society of Clinical Oncology (ASCO); 2003 May 31-Jun 3; Chicago. Alexandria (VA): ASCO; 2003;22:2.
4. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials. Non-small Cell Lung Cancer Collaborative Group. BMJ 1995;311:899-909.
5. Keller SM, Adak S, Wagner H, Herskovic A, Komaki R, Brooks BJ, et al. A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology Group. N Engl J Med 2000;343:1217-22.
6. Crino L, Clerici M, Figoli F, Carlini P, Ceci G, Cortesi E, et al. Chemotherapy of advanced non-small-cell lung cancer: a comparison of three active regimens. A randomized trial of the Italian Oncology Group for Clinical Research (G.O.I.R.C.). Ann Oncol 1995;6:347-53.
7. Kelly K, Crowley J, Bunn PA Jr, Presant CA, Grevstad PK, Moinpour CM, et al. Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small-cell lung cancer: a Southwest Oncology Group trial. J Clin Oncol 2001;19:3210-8.
8. Scagliotti GV, De Marinis F, Rinaldi M, Crino L, Gridelli C, Ricci S, et al. Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer. J Clin Oncol 2002;20:4285-91.
9. Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, Krook J, et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 2002;346:92-8.
10. Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials. PORT Meta-analysis Trialists Group. Lancet 1998;352: 257-63.
11. Legare RD, Strenger R. Adjuvant therapy in breast cancer. Obstet Gynecol Clin North Am 2002;29:201-8, ix.
12. Saltz LB, Minsky B. Adjuvant therapy of cancers of the colon and rectum. Surg Clin North Am 2002;82:1035-58.